Forma Therapeutics a clinical-stage biopharmaceutical company that specializes is in the development, research and commercialization of novel therapeutics to treat and create drug candidates for rare hematologic diseases and cancers, is proud to have Dr. Wayne A.I. Fredrick join its Board of Directors. Dr. Fredrick also currently serves as a board member for Humana, Inc., the United States Chamber for Commerce and Mutual of America Life Insurance Co.
“As a practicing physician and experienced medical researcher, coupled with his leadership skills and business acumen, Wayne brings valuable perspective to Forma at this pivotal time of growth for our company, particularly as we look to advance our sickle cell disease program into a Phase 2/3 pivotal trial next year,” said Peter Wirth, J.D., Chairman, Board of Directors of Forma.
“I am delighted to welcome such an experienced and sickle cell community-minded director to join us,” said Frank Lee, Chief Executive Officer and board member of Forma. “With his deep understanding of patient needs and his personal commitment to the sickle cell community, Wayne embodies Forma’s mission and patient-driven culture.”
Dr. Frederick holds many prestigious titles across the field of medicine and research, including being President of Howard University, Charles R. Drew Professor in Surgery at Howard University’s College of Medicine, a fellow of the American College of Surgeons, and is currently a distinguished researcher and practicing surgeon. Additionally, he has served as Howard’s Provost and Chief Academic Officer, been an author to numerous peer-reviewed articles, book chapters, abstracts, and editorials, and won multiple awards for his scholarship and service to the field.
“I am honored to join the board of a company that is committed to and passionate about pursuing treatments for rare hematologic diseases and cancers,” said Dr. Frederick. “As someone who is living with Sickle Cell, I am personally dedicated to the search for new and better therapeutics to combat this painful and debilitating disease. I am inspired by Frank and the team he has so diligently assembled for this cause.”